Interested in Developing Innovative Medical Technologies that Impact Human Health? 

The Master’s in Translational Medicine (MTM) program at The City College of New York (CCNY) is an exciting collaboration between The Grove School of Engineering and The CUNY School of Medicine / Sophie Davis Biomedical Education Program. By bringing a new type of graduate degree program to the academic landscape, our mission is to educate and train the next generation of leaders in healthcare innovation and medical technology commercialization.

Applications will be reviewed on a rolling basis.

The Application Deadline for Fall 2024 is Sunday, March 31, 2024.

Watch Jeffrey S. Garanich, Ph.D., Director of the Master’s in Translational Medicine (MTM) Program, and 2017 graduate Sadiq Rahman discuss the program’s goals and career opportunities after graduation.

Many graduate-level medical innovation programs highlight only one aspect of the ‘bench to bedside’ process. Our program is unique in that we explore and examine all facets of the medical technology innovation process from ideation to prototyping to clinical evaluation. The 3-semester Biodesign course sequence teaches students a hands-on approach to developing a functional medical technology or application to address a current unmet clinical need. Our students have the opportunity to interact with outstanding faculty, thought leaders and cutting edge experts in the medical technology industry who provide up-to-date advice and training in the quickly developing field of translational medicine. This approach is one that is engaging for engineers, scientists, researchers and others with a STEM background. By completing a stimulating curriculum and challenging program that fosters leadership, entrepreneurship, and innovation, our graduates will be ready to create and develop the medical technologies that will change the future of healthcare.